Cathepsin
Cathepsins (the term standing for “lysosomal proteolytic enzyme”) are a class of globular proteases that catalyze the hydrolysis of intracellular peptides and also exhibit extracellular functions. So far, a total of sixteen members of human cathepsin family have been identified, which are divided into three subfamilies, including cysteine protease family (cathepsin B, C, F, H, L, K, O, S, V, W, X and Z), serine carboxypeptidase family (cathepsin A and G) and aspartic protease family (cathepsin D and E). Cathepsins are highly expressed in various human cancers with each member playing different roles in distinct tumorigenic processes, including proliferation, angiogenesis, metastasis and invasion.
Products for Cathepsin
- Cat.No. Product Name Information
- GC11553 2-cyano-Pyrimidine cathepsin K inhibitor
- GC35111 3-Epiursolic Acid 3-Epiursolic Acid is a triterpenoid that can be isolated from Myrtaceae, acts as a competitive inhibitor of cathepsin L (IC50, 6.5 μM; Ki, 19.5 μM), with no obvious effect on cathepsin B.
- GC46885 Asperglaucide An amide with diverse biological activities
- GC40769 Asperphenamate Asperphenamate is a fungal secondary metabolite originally isolated from A.
- GC12751 Balicatib Cathepsin K inhibitor
- GC16317 CA 074 A selective cathepsin B inhibitor
- GC15917 CA-074 Me A cathepsin B and L inhibitor
- GC40694 Calpain Inhibitor II Calpain Inhibitor II (Calpain inhibitor II) is a potent inhibitor of calpain and cathepsin proteases.
- GC10342 Calpeptin A calpain inhibitor
- GC65998 Cathepsin C-IN-5 Cathepsin C-IN-5 (compound SF38) is a potent, selective and orally active Cathepsin C inhibitor with IC50s of 59.9 nM, 4.26 μM, >5 μM, >5 μM, >5 μM for Cat C, Cat L, Cat S, Cat B, Cat K, respectively. Cathepsin C-IN-5 inhibits the Cat C activity in bone marrow and blood. Cathepsin C-IN-5 decreases the activation of NSPs (neutrophil serine proteases). Cathepsin C-IN-5 shows anti-inflammatory activity.
- GC62889 Cathepsin D and E FRET Substrate acetate Cathepsin D and E FRET Substrate acetate is a fluorogenic substrate for cathepsins D and E and not for B, H or L. The cleavage occurs at the Phe-Phe amide bond resul. Cathepsin D and E FRET Substrate is a valuable tool for routine assays and for mechanistic studies on cathepsins E and D.
- GC10376 Cathepsin G Inhibitor I
-
GC16181
Cathepsin Inhibitor 1
Cathepsin inhibitor
- GC33892 Cathepsin Inhibitor 2 Cathepsin Inhibitor 2 is a potent Cathepsin S inhibitor extracted from patent WO2009123623A1, has a Ki of <20 nM.
- GC14903 Cathepsin S inhibitor A potent cathepsin S inhibitor
- GC19520 Cysteine Protease inhibitor Cysteine Protease inhibitor is an inhibitor of cysteine protease.
-
GC15708
Cysteine Protease inhibitor hydrochloride
inhibitor of cysteine protease
- GC62302 Cysteine protease inhibitor-2 Cysteine protease inhibitor-2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor-2 inhibits the cells growth of DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
-
GC13787
E 64d
A protease inhibitor
- GC13418 E-64 A fungal metabolite with diverse biological activities
- GC16505 E-64-c An active metabolite of E-64d
- GC68008 GÜ2602
- GC62634 GSK-2793660 GSK-2793660 (free base) is an oral, irreversible inhibitor of Cathepsin C (CTSC).
- GC60960 JPM-OEt JPM-OEt is a broad spectrum cysteine cathepsin inhibitor. JPM-OEt binds covalently in the active site, and irreversibly inhibits the cysteine cathepsin family. Antitumor activity.
- GC60212 K777 A cysteine protease inhibitor
- GC65153 KGP94 KGP94 is a selective inhibitor of cathepsin L with an IC50 of 189 nM. KGP94 inhibits migration and invasion of metastatic carcinoma and shows low cytotoxicity (GI50=26.9 ?M) against various human cell lines.
- GC17989 L 006235 An inibitor of cathepsin K
- GC31465 L-873724 L-873724 is a potent, orally bioavailable, selective and reversible non-basic cathepsin K inhibitor, with IC50s of 0.2, 178, 264, and 5239 nM for cathepsin K, cathepsin S, cathepsin L, cathepsin B, respectively.
- GC10027 Leupeptin, Microbial A reversible protease inhibitor
- GC38809 LHVS LHVS is a potent, non-selective, irreversible, cell-permeable cysteine protease and cathepsin inhibitor.
- GC65432 LV-320 LV-320 is a potent and uncompetitive ATG4B inhibitor with an IC50 of 24.5??M and a Kd of 16??M. LV-320 inhibits ATG4B enzymatic activity, blocks autophagic flux in cells, and is stable, non-toxic and active in vivo.
- GA23177 Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ is a fluorogenic substrate for cathepsins D and E and not for B, H or L.
- GC11640 MDL 28170 A cell permeable, selective calpain inhibitor
-
GC34682
N-Ethylmaleimide
A cysteine protease inhibitor
-
GC69551
N-Ethylmaleimide-d5
N-Ethylmaleimide-d5 is the deuterated form of N-Ethylmaleimide. N-Ethylmaleimide (NEM) is a reagent that alkylates free sulfhydryl groups and is a cysteine protease inhibitor. NEM specifically inhibits phosphate transport in mitochondria. It also acts as an inhibitor of deubiquitinating enzymes.
- GC34924 NSC 185058 An inhibitor of ATG4B
- GC16388 Odanacatib (MK-0822) Odanacatib (MK-0822) (MK-0822) is a potent and selective inhibitor of cathepsin K, with an IC50 of 0.2 nM for human cathepsin K.
- GC61158 ONO-5334 ONO-5334 is a potent, selective and orally active cathepsin K inhibitor with Ki values of 0.10 nM, 0.049 nM and 0.85 nM for human, rabbit and rat cathepsin K, respectively.
-
GC69651
p-Aminophenylmercuric acetate
p-Aminophenylmercuric acetate is an organic mercury-based matrix metalloproteinase (MMP) activator. It activates and inhibits MMP-8 by attacking protein thiol groups or inducing cysteine conversion reactions. p-Aminophenylmercuric acetate promotes the shedding of pro-BTC, a precursor to beta-fibrinogen. It also affects the binding of opioid receptors with their agonists and antagonists.
-
GC33829
Papain
Papain is a cysteine protease with wide specificity, cleaving peptide bonds of basic amino acids, leucine, or glycine.
- GC31856 Petesicatib Petesicatib is a cathepsin S inhibitor, used in research of immune diseases.
-
GC10477
PMSF
A nonspecific, irreversible serine protease inhibitor
- GC63856 Relacatib Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V with Ki values of 41 pM, 68 pM, and 53 pM, respectively.
-
GC69824
RO5461111
RO5461111 is a highly specific and orally effective Cathepsin S inhibitor (IC50: 0.4 nM, human Cathepsin S; 0.5 nM, murine Cathepsin S). It can effectively inhibit antigen-specific T cell and B cell activation. RO5461111 has an improvement effect on pulmonary inflammation and lupus nephritis.
- GC65307 S130 S130 is a high affinity, selective inhibitor of ATG4B (a major cysteine protease) with an IC50 of 3.24 ?M. S130 suppresses autophagy flux.
- GC10377 SID 26681509
- GC61791 SID 26681509 quarterhydrate SID 26681509 quarterhydrate is a potent, reversible, competitive, and selective inhibitor of human cathepsin L with an IC50 of 56 nM.
- GC32873 VBY-825 VBY-825 is a novel, reversible cathepsin inhibitor with high potency against cathepsins B, L, S and V.
- GA23863 Z-Leu-Val-Gly-diazomethylketone Z-Leu-Val-Gly-diazomethylketone is a cell-permeable and irreversible inhibitor of cysteine proteinase.